Spero Therapeutics, Inc.SPRONASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank22
Studio
Year-over-Year Change

Return on invested capital

Latest
-116.05%
↑ 57% vs avg
Percentile
P22
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-267.06%
Historical baseline
PeriodValueYoY Change
2024-116.05%-984.4%
202313.12%+132.6%
2022-40.25%+29.7%
2021-57.21%-1.3%
2020-56.49%+28.2%
2019-78.66%-114.4%
2018-36.68%+24.4%
2017-48.52%+90.0%
2016-484.70%+72.5%
2015-1765.17%-